Chapter Thirteen
Summary
Many patients presenting with various axis I conditions also use or abuse substances. We only tend to get
concerned when a client demonstrates detrimental effects on his/her social and occupational functioning. This
includes, but is not limited to, loss of control or compulsive use, the development of chemical tolerance, and
impairment or failure in meeting life’s major obligations such as work.
Research demonstrates that 61% of those with bipolar illness, 47% of those with schizophrenia, 39% of
those with a personality disorder, 33% of those with OCD, and 32% of those with an affective disorder abuse
substances. Determining whether the substance abuse condition or the mental illness came first may be, well,
difficult. Taking good history and determining if there is significant family history for mental illness or substance
abuse is the first order of business. Research has demonstrated that chronic alcohol use does in fact lead to
depressive illness.
Some research believes that addiction is not simply a direct effect of the drug on the brain, but a
pathological relationship one has with the drug. Further, when humans pursue gratification, they experience three
basic types of neurochemical responses: arousal, satiation, and fantasy. Each relates to a specific neurotransmitter.
For example, arousal involves norepinephrine and dopamine; satiation with GABA, and fantasy with serotonin.
Most drugs of abuse including cigarettes involve increasing the concentrations of dopamine in the brain’s
reward centers. Thus, most abusers start off seeking the “high,” but end up just using to avoid withdrawal.
Treatment centers tend to follow their own particular treatment philosophy. Some include more of a traditional
“moral” model like a 12 step AA program. Others may utilize a “rational recovery” model. In any case, treatment
must not assume that all mental health problems are caused by patient’s chemical abuse, nor is the use a result of
attempting to “self medicate” mental illness. Research has suggested that the patient’s level of rapport and alliance
with the treating clinician may in fact lead to more days of abstinence.